Randomized Trialhigh evidence
Laser Therapy for Sexual Health in Breast Cancer Survivors Receiving Aromatase Inhibitors: A Secondary Analysis of a Randomized Clinical Trial.
JAMA network open·October 1, 2026·PMID 42879157
Why it mattersBreast cancer survivors on aromatase inhibitors often have limited options for genitourinary syndrome of menopause, and laser therapy is increasingly marketed despite limited sham-controlled evidence. This trial provides high-quality evidence that laser therapy does not outperform sham, supporting reliance on nonhormonal therapies and avoiding unnecessary procedures.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled